ArticleTurkish journal of medical sciences2022

Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study.

Orhan Küçükşahin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.